| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296720A2 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 04/02/2003 | EP1296716A2 New formulation |
| 04/02/2003 | EP1296715A2 Multivalent vaccine composition |
| 04/02/2003 | EP1296712A2 Hiv-1 vaccines and screening methods therefor |
| 04/02/2003 | EP1296711A2 Human papilloma virus treatment |
| 04/02/2003 | EP1296710A1 Recombinant vaccines against infectious bursal disease virus |
| 04/02/2003 | EP1296707A1 Methods of treating viral diseases with il-18 and il-18 combinations |
| 04/02/2003 | EP1296703A1 Non-antibacterial tetracycline as anti-fungal agents |
| 04/02/2003 | EP1296702A1 Neuroprotective peptides |
| 04/02/2003 | EP1296699A1 Therapeutic agents - iii |
| 04/02/2003 | EP1296698A1 Therapeutic agents - ii |
| 04/02/2003 | EP1296697A1 Therapeutic agents - i |
| 04/02/2003 | EP1296696A1 Herbal composition for the treatment and curing of diseases |
| 04/02/2003 | EP1296693A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES |
| 04/02/2003 | EP1296688A2 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide, oxy amide or 8-hydroxy quinoline structure |
| 04/02/2003 | EP1296685A1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 04/02/2003 | EP1296680A2 The method of treating drug resistant mycobacterium tuberculosis infection |
| 04/02/2003 | EP1296673A1 Antimicrobial coatings |
| 04/02/2003 | EP1296670A1 Therapeutic combinations of fatty acids |
| 04/02/2003 | EP1296664A2 Propofol for treatment of sepsis |
| 04/02/2003 | EP1296659A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 04/02/2003 | EP1296656A2 Method for preparing a composition |
| 04/02/2003 | EP1296652A1 Topical pharmaceutical formulations and methods of treatment |
| 04/02/2003 | EP1296648A1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/02/2003 | EP1296646A2 Oral pharmaceutical compositions containing terbinafine |
| 04/02/2003 | EP1296644A2 Systems and methods for treating a mucosal surface |
| 04/02/2003 | EP1296636A1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES |
| 04/02/2003 | EP1296633A1 Medicinal product package for eradication therapy |
| 04/02/2003 | EP1246627A4 Polyanhydrides with biologically active degradation products |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1131091B1 Treatment of viral hemorrhagic fever with protein c |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 04/02/2003 | EP1071677A4 Production of furanones |
| 04/02/2003 | EP0986570B1 Gemcitabine derivatives |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0831900B1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 04/02/2003 | EP0830380B1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 04/02/2003 | EP0804236B1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 04/02/2003 | EP0774513B1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 04/02/2003 | EP0772595B1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
| 04/02/2003 | EP0763049B1 Nucleoside monophosphate derivatives, a process for their production and their use as immunosuppressive drugs |
| 04/02/2003 | EP0677114B1 Recombinant swinepox virus |
| 04/02/2003 | EP0623169B1 Hepatitis e virus vaccine and method |
| 04/02/2003 | EP0621865B1 Rapamycin derivative and its medicinal use |
| 04/02/2003 | EP0588912B1 Blended carboxylic acid sanitizer |
| 04/02/2003 | CN1408021A Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 04/02/2003 | CN1407987A Hexahydrofuro'2,3-Blfuran-3-yl-N-´¢ø3'(1,3-benzodioxol-5-ylsulfonyl)(isobutyl) Aminol-1-benzyl-2-hydroxypropyl´¢Øcarbamate as retroviral protease inhibitor |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1406630A Composite enzyme reacting liquid |
| 04/02/2003 | CN1406616A Tablets against viral myocarditis |
| 04/02/2003 | CN1406615A Medicine against for beriberi and sore and boil |
| 04/02/2003 | CN1406585A Medicinal composition for viral myocarditis |
| 04/02/2003 | CN1406523A Oral liquid production |
| 04/02/2003 | CN1104436C Vinyl pyrrolidine cephalosporins with basic substituents |
| 04/02/2003 | CN1104434C Optical pure analogs of camptothecinum and composition and use thereof |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
| 04/02/2003 | CN1104248C Chinese medicine for treating tuberculosis and hepatitis |
| 04/02/2003 | CN1104240C Composition comprising amoxycillin and clavulanic acid, its preparation and use |
| 04/02/2003 | CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate |
| 04/01/2003 | US6542858 Pharmacokinetic-based drug design tool and method |
| 04/01/2003 | US6541672 Showing anti-bacterial, antioxidant, and anti-inflammatory activities that enable them to be used for drugs |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541518 Preventing pathogens in blood plasma and for enhancing the production of cryoprecipitate from plasma by adding a low molecular weight carboxylic acid or salt to the plasma, preferably trisodium citrate |
| 04/01/2003 | US6541510 Cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus, especially HIV. |
| 04/01/2003 | US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541496 Inhibitors of IMPDH enzyme |
| 04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
| 04/01/2003 | US6541485 Urea substituted imidazoquinolines |
| 04/01/2003 | US6541483 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 04/01/2003 | US6541482 Autoimmune disease |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | US6541459 Soluble herpesvirus glycoprotein complex vaccine |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 04/01/2003 | US6541248 Genome comprising nucleotide sequence encoding an anti-sense RNA or ribozyme; cleavage of a second nucleotide sequence which encodes a polypeptide; use in gene therapy |
| 04/01/2003 | US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion |
| 04/01/2003 | US6541015 Water soluble prodrug with a biologically active agent link trapped in a hydrogel and controllably released by diffusion |
| 04/01/2003 | US6541010 Alphavirus RNA replicon systems |
| 04/01/2003 | US6541009 Viral vaccines |
| 04/01/2003 | US6541007 Vaccine for Pseudomonas aeruginosa |
| 04/01/2003 | US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier |
| 04/01/2003 | US6541002 Rendering a polypeptide capable of binding with virion by altering the polypeptide such that the altered polypeptide comprises a Vpr-binding region having specific amino acid sequence |
| 04/01/2003 | US6541001 A stable compacted, compressed or hard tableted vaccine formulation containing a freeze dried antigenic component and a dissolution aid |